Retrieve available abstracts of 37 articles: HTML format
Single Articles
June 2025
SINGH D, Chandran A, Panebianco V, Vilaseca J, et al MRI capacity assessment for prostate cancer screening in five sites of Europe.
Eur J Radiol. 2025;190:112235. PubMedAbstract available
May 2025
SHIN JI, Park KJ, Park MY, Kim MH, et al Diagnostic performance of biparametric MRI according to prostate imaging quality
(PI-QUAL) version 2: Analysis of Multi-Institutional Data.
Eur J Radiol. 2025;189:112209. PubMedAbstract available
March 2025
ZHU W, Tang Y, Qi L, Gao X, et al Machine learning models for enhanced diagnosis and risk assessment of prostate
cancer with (68)Ga-PSMA-617 PET/CT.
Eur J Radiol. 2025;186:112063. PubMedAbstract available
NIEUWENHOVE SV, Lhommel R, Pasoglou V, Damme JV, et al Fast (< 30 min) "All-in-One" whole-body MRI for TNM staging in high-risk prostate
cancer (PCa): Feasibility and comparison to (68)Ga-Prostate Specific Membrane
Antigen (PSMA)-PET/CT.
Eur J Radiol. 2025;186:112033. PubMedAbstract available
PAUSCH AM, Elsner C, Rupp NJ, Eberli D, et al Comparative analysis of TARGET and PI-FAB scores in mpMRI surveillance after HIFU
therapy for localized prostate cancer.
Eur J Radiol. 2025;186:112028. PubMedAbstract available
February 2025
TOKUDA B, Yamada K, Kozawa N, Takahata A, et al Temporal Evolution of multiparametric magnetic resonance imaging findings
following lesion-targeted focal microwave tissue coagulation for localized
prostate cancer.
Eur J Radiol. 2025;185:111995. PubMedAbstract available
PAUSCH AM, Ghafoor S, Notter R, Benke-Bruderer S, et al MRI-based risk stratification for clinically significant prostate cancer
detection at biopsy: The value of zonal-specific PSA density and PSHS.
Eur J Radiol. 2025;184:111982. PubMedAbstract available
WALTER-RITTEL TC, Frisch A, Hamm CA, Baumgartner GL, et al Automated 24-sector grid-map algorithm for prostate mpMRI improves precision and
efficacy of prostate lesion location reporting.
Eur J Radiol. 2025;183:111897. PubMedAbstract available
December 2024
PONSIGLIONE A, Stanzione A, Minieri A, Musella R, et al Impact of software-assisted structured reporting on radiology residents
approaching prostate MRI.
Eur J Radiol. 2024;183:111889. PubMedAbstract available
ASFUROGLU U, Asfuroglu BB, Ozer H, Inan MA, et al A comparative analysis of techniques for measuring tumor contact length in
predicting extraprostatic extension.
Eur J Radiol. 2024;181:111753. PubMedAbstract available
October 2024
BAYERL N, Adams LC, Cavallaro A, Bauerle T, et al Assessment of a fully-automated diagnostic AI software in prostate MRI: Clinical
evaluation and histopathological correlation.
Eur J Radiol. 2024;181:111790. PubMedAbstract available
KLEIBURG F, de Geus-Oei LF, Luelmo SAC, Spijkerman R, et al PSMA PET/CT for treatment response evaluation at predefined time points is
superior to PSA response for predicting survival in metastatic
castration-resistant prostate cancer patients.
Eur J Radiol. 2024;181:111774. PubMedAbstract available
September 2024
PONSIGLIONE A, Cereser L, Spina E, Mannacio L, et al PI-QUAL version 2: A Multi-Reader reproducibility study on multiparametric MRI
from a tertiary referral center.
Eur J Radiol. 2024;181:111716. PubMedAbstract available
August 2024
YADAV D, Dutruel SP, O'Dwyer E, Ricaurte-Fajardo A, et al PSMA PET improves characterization of dural-based intracranial lesions in
patients with metastatic prostate cancer.
Eur J Radiol. 2024;180:111711. PubMedAbstract available
BECKER AS, Woo S, Leithner D, Tong A, et al The "Hungry Judge" effect on prostate MRI reporting: Chronobiological trends from
35'004 radiologist interpretations.
Eur J Radiol. 2024;179:111665. PubMedAbstract available
June 2024
KLUCKERT J, Hotker AM, Da Mutten R, Konukoglu E, et al AI-based automated evaluation of image quality and protocol tailoring in patients
undergoing MRI for suspected prostate cancer.
Eur J Radiol. 2024;177:111581. PubMedAbstract available
April 2024
FRANSEN SJ, Roest C, Van Lohuizen QY, Bosma JS, et al Using deep learning to optimize the prostate MRI protocol by assessing the
diagnostic efficacy of MRI sequences.
Eur J Radiol. 2024;175:111470. PubMedAbstract available
PAUSCH AM, Elsner C, Rupp NJ, Eberli D, et al MRI-based monitoring of prostate cancer after HIFU: Inter-reader agreement and
diagnostic performance of the PI-FAB score.
Eur J Radiol. 2024;175:111463. PubMedAbstract available
March 2024
QUENTIN M, Boschheidgen M, Radtke JP, Spohn F, et al MRI in-bore biopsy following MRI/US fusion-guided biopsy in patients with
persistent suspicion of clinically significant prostate cancer.
Eur J Radiol. 2024;175:111436. PubMedAbstract available
January 2024
GIGANTI F, Asbach P The backbone of prostate MRI: Technical acquisition and image quality.
Eur J Radiol. 2024;172:111320. PubMed
December 2023
REN X, Nur Salihin Yusoff M, Hartini Mohd Taib N, Zhang L, et al (68)Ga-prostate specific membrane antigen-11 PET/CT versus multiparametric MRI in
the detection of primary prostate cancer: A systematic review and head-to-head
comparative meta-analysis.
Eur J Radiol. 2023;170:111274. PubMedAbstract available
HARTH C, De Vulder N, Hermie L, Vanlangenhove P, et al Stereotactic transgluteal prostatic biopsy using Cone-Beam CT navigation and
prebiopsy MRI image fusion in a patient without rectal access.
Eur J Radiol. 2023;170:111265. PubMed
KHAN A, Moore CM, Minhaj Siddiqui M Prostate MRI and image quality: The urologist's perspective.
Eur J Radiol. 2023;170:111255. PubMedAbstract available
WENDEROTT K, Krups J, Luetkens JA, Gambashidze N, et al Prospective effects of an artificial intelligence-based computer-aided detection
system for prostate imaging on routine workflow and radiologists' outcomes.
Eur J Radiol. 2023;170:111252. PubMedAbstract available
November 2023
PAUSCH AM, Ghafoor S, Kluckert J, Rupp NJ, et al Risk factors for prostate cancer in men with false-negative mpMRI: A
retrospective single center cohort study of image quality scores and clinical
parameters.
Eur J Radiol. 2023;170:111227. PubMedAbstract available
AGGARWAL P, Singh H, Das CK, Mavuduru RS, et al Potential role of (68)Ga-PSMA PET/CT in metastatic renal cell cancer: A
prospective study.
Eur J Radiol. 2023;170:111218. PubMedAbstract available
REHMAN I, Pang E, Harris AC, Chang SD, et al Bi-parametric prostate MRI with a recall system for contrast enhanced imaging:
Improving accessibility while maintaining quality.
Eur J Radiol. 2023;169:111186. PubMedAbstract available
FLEMING H, Dias AB, Talbot N, Li X, et al Inter-reader variability and reproducibility of the PI-QUAL score in a
multicentre setting.
Eur J Radiol. 2023;168:111091. PubMedAbstract available
October 2023
AL-MONAJJED R, Radtke JP, Thomas M, Boschheidgen M, et al Multiparametric MRI characteristics of prostatitis and atrophy in the peripheral
zone in men without prostate cancer.
Eur J Radiol. 2023;169:111151. PubMedAbstract available
ZHANG KS, Mayer P, Glemser PA, Tavakoli AA, et al Are T2WI PI-RADS sub-scores of transition zone prostate lesions biased by DWI
information? A multi-reader, single-center study.
Eur J Radiol. 2023;167:111026. PubMedAbstract available
SABBAH M, Gutierrez P, Puech P MA-QC: Free online software for prostate MR quality control and PI-QUAL
assessment.
Eur J Radiol. 2023;167:111027. PubMedAbstract available
September 2023
SINGH S, Giganti F, Dickinson L, Rogers H, et al Prostate MR image quality of apparent diffusion coefficient maps versus
fractional intracellular volume maps from VERDICT MRI using the PI-QUAL score and
a dedicated Likert scale for artefacts.
Eur J Radiol. 2023;168:111109. PubMedAbstract available
YILMAZ EC, Harmon SA, Belue MJ, Merriman KM, et al Evaluation of a Deep Learning-based Algorithm for Post-Radiotherapy Prostate
Cancer Local Recurrence Detection Using Biparametric MRI.
Eur J Radiol. 2023;168:111095. PubMedAbstract available
August 2023
THIJSSEN LCP, de Rooij M, Barentsz JO, Huisman HJ, et al Radiomics based automated quality assessment for T2W prostate MR images.
Eur J Radiol. 2023;165:110928. PubMedAbstract available
DEIVASIGAMANI S, Kotamarti S, Adams ES, Seguier D, et al Reconciling discordance between PI-RADS 4 lesions and targeted biopsy: Early
experience of a multidisciplinary quality improvement protocol with PI-RADS 4
subcategorization.
Eur J Radiol. 2023;165:110929. PubMedAbstract available
June 2023
URSPRUNG S, Herrmann J, Joos N, Weiland E, et al Accelerated diffusion-weighted imaging of the prostate using deep learning image
reconstruction: A retrospective comparison with standard diffusion-weighted
imaging.
Eur J Radiol. 2023;165:110953. PubMedAbstract available
ZHANG KS, Neelsen CJO, Wennmann M, Glemser PA, et al Same-day repeatability and Between-Sequence reproducibility of Mean ADC in
PI-RADS lesions.
Eur J Radiol. 2023;165:110898. PubMedAbstract available